Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average of ...

Evernorth's Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs, the company ...

Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to ...

Tricare beneficiaries may now receive specialty drugs at lower copays through Tricare Home Delivery, according to the ...

AbbVie (ABBV) shares were down 6% in the wake of its Q1 earnings report and news that Cigna (CI) plans to offer a Humira ...

In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar ...

Shares of AbbVie (NYSE:ABBV) sank on Friday after the pharmaceutical company reported first-quarter results. Despite beating ...

Texas town thrives by offering state and local corporate tax incentives, office retention incentives and tax abatements.

Anglo American has rejected BHP’s acquisition proposal of $38.88 billion, stating it significantly undervalues the company ...

Following is a summary of current health news briefs. US senators push for bird-flu response as FDA reports milk findings. Some U.S. lawmakers urged the Biden administration on Fr ...

Evernorth Health Services will offer Humira biosimilar products with no out-of-pocket cost through its Accredo specialty ...

By Ben Glickman Cigna Group-owned Evernorth Health Services said Thursday it would provide a Humira biosimilar with no out-of-pocket fees starting in ...